Treace Medical Concepts

Treace Medical Concepts

Quarterly Financials

Values in thousands2026-09-302026-06-302026-03-312025-12-31
Revenue
$48,253
$45,376
$47,198
$62,519
Gross Profit
38,350
35,607
37,407
50,401
EBITDA
-10,982
-12,423
-15,492
-5,163
EBIT
-10,982
-14,311
-16,391
-8,044
Net Income
-12,566
-15,873
-17,961
-9,394
Net Change In Cash
48,253
45,376
47,198
62,519
Free Cash Flow
-5,426
-6,899
4,171
-10,424
Cash
7,760
12,610
9,544
10,708
Basic Shares
65,464
65,049
64,592
63,860

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$212,690
$209,357
$187,118
$141,838
Gross Profit
169,752
168,264
151,937
114,315
EBITDA
-43,182
-42,068
-39,008
-36,284
EBIT
-53,682
-50,487
-44,360
-38,417
Net Income
-59,002
-55,743
-49,527
-42,815
Net Change In Cash
212,690
209,357
187,118
141,838
Cost of Revenue
-86,360
Free Cash Flow
-29,487
-48,760
-46,033
-45,486
Cash
10,708
11,350
12,982
19,473
Basic Shares
63,269
62,112
60,852
55,276

Earnings Calls

QuarterEPS
2026-09-30
-$0.19
2026-06-30
-$0.24
2026-03-31
-$0.28
2025-12-31
-$0.07